News | October 04, 2024
SK pharmteco invests US$ 260 million to expand global small molecule, peptide production
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Establishing Asymchem’s first manufacturing footprint in Europe
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
Subscribe To Our Newsletter & Stay Updated
